K. Gulya et al., [D-PEN(2),D-PEN(5)]ENKEPHALIN, A DELTA-OPIOID AGONIST, REDUCES ENDOGENOUS ALUMINUM CONTENT IN THE RAT CENTRAL-NERVOUS-SYSTEM, Neuroscience, 66(2), 1995, pp. 499-506
The in vivo effects of [D-Pen(2),D-Pen(5)]enkephalin, a cyclic peptide
agonist with high affinity and selectivity for the delta opioid recep
tors, on the endogenous aluminum content of selected areas of rat brai
n and spinal cord were studied by means of atomic absorption spectroph
otometry. intracerebroventricular injection of a subanalgesic dose of
[D-Pen(2),D-Pen(5)]enkephalin (0.2 mu g/3 mu l) produced a transient,
time-dependent reduction of the aluminum content. This effect was stat
istically significant in the frontal cortex, hippocampus and striatum,
but did not reach the level of significance in the medulla and thorac
ic spinal cord. The partial depleting effect of [D-Pen(2),D-Pen(5)]enk
ephalin on aluminum content, in the range of 0.2-1.0 mu g/3 mu l, was
dose-dependent and could be reversed by naloxone pretreatment. Serum a
luminum levels were unchanged after [D-Pen(2),D-Pen(5)]enkephalin trea
tment. Chronic (five weeks), systemic AlCl3, treatment increased the e
ndogenous aluminum content in all central nervous system areas examine
d. Interestingly, [D-Pen(2),D-Pen(5)]enkephalin i.c.v. produced a slig
ht depletion of this elevated metal level in these areas to values not
significantly different from those of the respective control values.
Chronic in vivo, as well as in vitro, effects of aluminum on opioid re
ceptor binding characteristics were also studied. Neither the specific
binding of [H-3][D-Pen(2),D-Pen(5)]enkephalin nor [H-3]Tyr-D-Ala-Gly-
NMePhe-Gly-ol to membranes of frontal or parietal cortices, striatum o
r hippocampus, prepared from rats chronically treated with AlCl3, were
affected. Moreover, aluminum ions in vitro did not alter either the s
pecific binding of [H-3]DPDPE or [H-3]Tyr-D-Ala-Gly-NMePhe-Gly-ol to r
at cerebral membranes prepared from control animals, suggesting not on
ly that chronic, systemic aluminum treatment failed to be neurotoxic t
o central delta or mu opioid receptor systems in vivo, but also the ab
sence of a direct receptor protein-metal ion interaction at these site
s in vitro. It is concluded that [D-Pen(2),D-Pen(5)]enkephalin, and pe
rhaps endogenous opioid peptides as well, via specific delta opioid re
ceptors, may regulate endogenous aluminum levels or exert a modulatory
action in mediating this phenomenon in the central nervous system of
the rat.